ESMO Clinical Practice Guidelines: CNS malignancies
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
The ESMO Clinical Practice Guidelines on Central Nervous System Malignancies currently focus on high-grade malignant glioma (newly diagnosed patients, glioblastoma (WHO grade IV) and anaplastic astrocytoma, oligoastrocytoma and oligodendroglioma (WHO grade III))and include information on:
- staging and risk assessment
- response evaluation and follow-up
High-grade malignant glioma
Authors: R. Stupp,J.-C. Tonn, M. Brada,G. Pentheroudakis
Read the guideline in PDF